View Older Stories View More Recent Stories
-
BMO Capital Downgrades Kate Spade (KATE) to Market Perform
-
BMO Capital Downgrades The Andersons, Inc. (ANDE) to Market Perform
-
BMO Capital Downgrades Archer Daniels Midland (ADM) to Market Perform
-
Halozyme Therapeutics (HALO) Surges Following Impressive Data for PEGPH20 in Pancreatic Cancer from Investor Day
-
Eli Lilly's 2015 Guidance Shows That Zoetis (ZTS) is Undervalued - BMO Capital
-
Arena Pharma (ARNA) APD334 Data Positive But Well Behind S1P1 Competitors - BMO Capital
-
BMO Capital Downgrades Mallinckrodt plc (MNK) to Market Perform
-
BMO Capital Upgrades Centene (CNC) to Outperform
-
BMO Capital Starts James River Group Holdings (JRVR) at Outperform
-
Notable Analyst Rating Changes 1/5: (LULU) (SKUL) (INTC) Upgraded; (SKH) (SBUX) (CVC) Downgraded
-
BMO Capital Starts Qorvo Inc (QRVO) at Market Perform
-
Notable Analyst Rating Changes 12/23: (ATW) (KMB) (CHD) Upgraded; (ACHN) (AVP) (RIG) Downgraded
-
BMO Capital Upgrades Kimberly Clark (KMB) to Outperform
-
BMO Capital Upgrades Church & Dwight Co. Inc. (CHD) to Outperform
-
BMO Capital Downgrades Avon Products (AVP) to Underperform
-
Streetinsider.com's Hot Lunchtime Reads 12/22: (GILD) (CUBA) (VHC) (ACHN)
-
Buy Gilead Sciences (GILD) on Weakness, BMO Capital Says; PT Dropped $20 on News
-
AbbVie's (ABBV) VIEKIRA PAK Seen as Limited Threat to Gilead's (GILD) HCV Dominance, BMO Capital Says
-
Celgene (CELG) Bullish Stance Reiterated at BMO Capital Amid Expanded EU Labeling
-
BMO Capital Starts LDR Holding (LDRH) at Outperform
-
Tetraphase Pharmaceuticals (TTPH) PT Raised to $48 at BMO Capital
-
Valeant Pharmaceuticals (VRX) Named Top Pick for 2015 at BMO Capital
-
Auspex Pharmaceuticals (ASPX) SD-809 Results 'Stunning', BMO Capital Says; PT Raised to $60
-
LendingClub (LC) IPO Tops $1B Following Over-Allotments
-
Devry (DV) Brasil Announces Agreement to Acquire Damásio Educacional
-
Genfit Data Not Seen as Competitive Threat to Intercept Pharmaceuticals (ICPT) - BMO Capital
-
Patriot National, Inc. (PN) Files for $100M IPO
-
BMO Capital Downgrades EnCana Corp. (ECA) to Market Perform
-
BMO Capital Upgrades Enerplus (ERF) to Market Perform
-
BMO Capital Downgrades Cenovus Energy Inc. (CVE) to Market Perform
-
BMO Capital Upgrades ExxonMobil (XOM) to Market Perform
-
UPDATE: Credit Suisse Positive on Canadian Banks; Downgrades CIBC (CM), Upgrades BMO (BMO)
-
James River Group (JRVR) IPO Opens Modestly HIgher
-
James River Group (JRVR) Prices IPO at $21, Slightly Below Expected Range
-
Flexion Therapeutics (FLXN) Prices Larger 5.04M Common Offering at $17/Share
-
IPO for Peer-to-Peer Lender LendingClub (LC) Opens Up 65%
-
LendingClub (LC) IPO Prices at $15, Above Expected Range
-
Notable 52-Week Highs and 12/10: (UAL) (BLUE) (BMS) High; (OAS) (CVEO) (CONN) Low
-
BMO Capital Upgrades American Eagle Outfitters (AEO) to Outperform
-
BMO Capital Upgrades Bemis (BMS) to Outperform
-
Flexion Therapeutics (FLXN) Announces 3.5M Common Offering
-
Notable 52-Week Highs and Lows 12/8: (JNS) (CELG) (JBLU) High; (WLL) (YNDX) (SNI) Low
-
BMO Capital Downgrades Eclipse Resources (ECR) to Market Perform (Earlier)
-
BMO Capital Downgrades EXCO Resources (XCO) to Underperform
-
BMO Capital Upgrades SM Energy (SM) to Outperform (Earlier)
-
BMO Capital Downgrades Approach Resources (AREX) to Underperform
-
BMO Capital Downgrades Energy XXI (EXXI) to Market Perform
-
BMO Capital Downgrades Goodrich Petroleum (GDP) to Market Perform
-
BMO Capital Downgrades Sanchez Energy (SN) to Market Perform
-
BMO Capital Downgrades Halcon Resources (HK) to Market Perform

